Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A

Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health

What You Should Know:

– DTx and Patient Support leaders, Amalgam Rx, Inc., announce the acquisition of Avhana Health, a privately-held clinical decision support (CDS) company.


Amalgam Rx, Inc., a Wilmington,
DE-based Digital Therapeutics and Patient Support company, announces the acquisition
of Avhana Health, a privately held
clinical decision support (CDS) company, which has deep integrations with the
leading electronic health records (EHR). As part of the acquisition, Amalgam Rx
will expand Avhana’s CDS tools to multiple therapeutic areas and combine them
with other digital solutions to simplify doctors’ workflows.

Founded in 2014, Avhana Health is a clinical decision
support startup used by doctors to support real-time adoption of and adherence
to clinical quality guidelines. Avhana’s SaaS-based CDS tool has been
implemented in more than 150 provider groups and identifies over $120 million a
year in cost savings. Enabling real-time two-way interactions within the EHR, Avhana optimizes
provider workflow beyond simple data integration.

“EHR integration is the Holy Grail for digital health solutions, but it’s not only about data integration; workflow optimization is even more important. Providers, working at the nexus of digital health adoption and scaling, will only adopt tools that are safe, effective, and embedded in their workflow. The combination of Avhana and Amalgam will bring us closer to realizing digital health’s tremendous potential,” said Ryan Sysko, chief executive officer of Amalgam Rx.